Screener
Clover Health Investments CLOV EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Clover Health Investments’s reported figures.
Based on trailing twelve months.
The source filing: Clover Health Investments’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 8:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001801170-26-000122
FAQ
- What is Clover Health Investments's EBITDA margin?
- Clover Health Investments (CLOV) reported EBITDA margin of -2.5% in Q1 2026.
- How has Clover Health Investments's EBITDA margin changed year-over-year?
- Clover Health Investments's EBITDA margin decreased by 62.4% year-over-year, from -1.5% to -2.5%.
- What is the long-term trend for Clover Health Investments's EBITDA margin?
- Over 4 years (2020 to 2025), Clover Health Investments's EBITDA margin has grown at a -24.9% compound annual growth rate (CAGR), from -13.7% to -4.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Clover Health Investments's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude